These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8473726)

  • 41. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y; Watts TH
    J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells.
    Bertolino P; Forquet F; Pont S; Koch N; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1991 May; 3(5):435-43. PubMed ID: 1655000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme.
    Demotz S; Grey HM; Appella E; Sette A
    Nature; 1989 Dec; 342(6250):682-4. PubMed ID: 2480524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
    Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
    J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HEL-Flu: an influenza virus containing the hen egg lysozyme epitope recognized by CD4+ T cells from mice transgenic for an alphabeta TCR.
    Walker WS; Castrucci MR; Sangster MY; Carson RT; Kawaoka Y
    J Immunol; 1997 Sep; 159(6):2563-6. PubMed ID: 9300673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
    Lambert LE; Unanue ER
    J Immunol; 1989 Aug; 143(3):802-7. PubMed ID: 2787347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular interference with antigen presentation.
    Leyva-Cobian F; Unanue ER
    J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds.
    Merkel BJ; Mandel R; Ryser HJ; McCoy KL
    J Immunol; 1995 Jan; 154(1):128-36. PubMed ID: 7995932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell.
    Nelson CA; Petzold SJ; Unanue ER
    Nature; 1994 Sep; 371(6494):250-2. PubMed ID: 8078585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
    Adorini L; Moreno J; Momburg F; Hämmerling GJ; Guéry JC; Valli A; Fuchs S
    J Exp Med; 1991 Oct; 174(4):945-8. PubMed ID: 1919443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
    Bonifaz LC; Arzate S; Moreno J
    Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and quantitation of a minor determinant of hen egg white lysozyme bound to I-Ak by using peptide-specific immunoaffinity.
    Gugasyan R; Vidavsky I; Nelson CA; Gross ML; Unanue ER
    J Immunol; 1998 Dec; 161(11):6074-83. PubMed ID: 9834091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Weak base amines can inhibit class I MHC-restricted antigen presentation.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the B cell antigen receptor in antigen processing and presentation. Involvement of the transmembrane region in intracellular trafficking of receptor/ligand complexes.
    Liu KJ; Parikh VS; Tucker PW; Kim BS
    J Immunol; 1993 Dec; 151(11):6143-54. PubMed ID: 8245457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.